A randomized dose-response trial of aerobic exercise and health-related quality of life in colon cancer survivors

Justin C. Brown, Nevena Damjanov, Kerry S. Courneya, Andrea B. Troxel, Babette S. Zemel, Michael R. Rickels, Bonnie Ky, Andrew D. Rhim, Anil K. Rustgi, Kathryn H. Schmitz

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Objective: To examine the dose-response effects of aerobic exercise on health-related quality of life (HRQoL) among colon cancer survivors. Methods: Thirty-nine stage I to III colon cancer survivors were randomized to 1 of 3 groups: usual-care control, 150 min·wk −1 of aerobic exercise (low-dose) and 300 min·wk −1 of aerobic exercise (high-dose) for 6 months. HRQoL outcomes included the Short Form (SF)-36 physical and mental component summary, Functional Assessment of Cancer Therapy-Colorectal, Pittsburgh Sleep Quality Index, Fear of Cancer Recurrence Inventory, Fatigue Symptom Inventory, and North Central Cancer Treatment Group bowel function questionnaire, assessed at baseline and post intervention. The primary hypothesis was that exercise would improve HRQoL outcomes in a dose-response fashion, such that high-dose aerobic exercise would yield the largest improvements in HRQoL outcomes. Results: Over 6 months, the low-dose group completed 141 ± 10 min·wk −1 of aerobic exercise, and the high-dose group completed 247 ± 11 min·wk −1 of aerobic exercise. Over 6 months, exercise improved the physical component summary score of the SF-36 (P trend  = 0.002), the Functional Assessment of Cancer Therapy-Colorectal (P trend  = 0.025), the Pittsburgh Sleep Quality Index (P trend  = 0.049), and the Fatigue Symptom Inventory (P trend  = 0.045) in a dose-response fashion. Between-group standardized mean difference effects sizes for the above-described findings were small to moderate in magnitude (0.35–0.75). No dose-response effects were observed for the mental component summary score of the SF-36, the Fear of Cancer Recurrence Inventory, or bowel function. Conclusion: Higher doses of aerobic exercise, up to 300 min·wk −1 , improve multiple HRQoL outcomes among stage I to III colon cancer survivors. These findings provide evidence that aerobic exercise may provide multiple health benefits for colon cancer survivors.

Original languageEnglish (US)
Pages (from-to)1221-1228
Number of pages8
JournalPsycho-Oncology
Volume27
Issue number4
DOIs
StatePublished - Apr 2018

Fingerprint

Colonic Neoplasms
Survivors
Quality of Life
Exercise
Equipment and Supplies
Fear
Fatigue
Colorectal Neoplasms
Sleep
Recurrence
Neoplasms
Insurance Benefits
Therapeutics

All Science Journal Classification (ASJC) codes

  • Experimental and Cognitive Psychology
  • Oncology
  • Psychiatry and Mental health

Cite this

Brown, Justin C. ; Damjanov, Nevena ; Courneya, Kerry S. ; Troxel, Andrea B. ; Zemel, Babette S. ; Rickels, Michael R. ; Ky, Bonnie ; Rhim, Andrew D. ; Rustgi, Anil K. ; Schmitz, Kathryn H. / A randomized dose-response trial of aerobic exercise and health-related quality of life in colon cancer survivors. In: Psycho-Oncology. 2018 ; Vol. 27, No. 4. pp. 1221-1228.
@article{8f349a72454e4634872647cacf2dfaa2,
title = "A randomized dose-response trial of aerobic exercise and health-related quality of life in colon cancer survivors",
abstract = "Objective: To examine the dose-response effects of aerobic exercise on health-related quality of life (HRQoL) among colon cancer survivors. Methods: Thirty-nine stage I to III colon cancer survivors were randomized to 1 of 3 groups: usual-care control, 150 min·wk −1 of aerobic exercise (low-dose) and 300 min·wk −1 of aerobic exercise (high-dose) for 6 months. HRQoL outcomes included the Short Form (SF)-36 physical and mental component summary, Functional Assessment of Cancer Therapy-Colorectal, Pittsburgh Sleep Quality Index, Fear of Cancer Recurrence Inventory, Fatigue Symptom Inventory, and North Central Cancer Treatment Group bowel function questionnaire, assessed at baseline and post intervention. The primary hypothesis was that exercise would improve HRQoL outcomes in a dose-response fashion, such that high-dose aerobic exercise would yield the largest improvements in HRQoL outcomes. Results: Over 6 months, the low-dose group completed 141 ± 10 min·wk −1 of aerobic exercise, and the high-dose group completed 247 ± 11 min·wk −1 of aerobic exercise. Over 6 months, exercise improved the physical component summary score of the SF-36 (P trend  = 0.002), the Functional Assessment of Cancer Therapy-Colorectal (P trend  = 0.025), the Pittsburgh Sleep Quality Index (P trend  = 0.049), and the Fatigue Symptom Inventory (P trend  = 0.045) in a dose-response fashion. Between-group standardized mean difference effects sizes for the above-described findings were small to moderate in magnitude (0.35–0.75). No dose-response effects were observed for the mental component summary score of the SF-36, the Fear of Cancer Recurrence Inventory, or bowel function. Conclusion: Higher doses of aerobic exercise, up to 300 min·wk −1 , improve multiple HRQoL outcomes among stage I to III colon cancer survivors. These findings provide evidence that aerobic exercise may provide multiple health benefits for colon cancer survivors.",
author = "Brown, {Justin C.} and Nevena Damjanov and Courneya, {Kerry S.} and Troxel, {Andrea B.} and Zemel, {Babette S.} and Rickels, {Michael R.} and Bonnie Ky and Rhim, {Andrew D.} and Rustgi, {Anil K.} and Schmitz, {Kathryn H.}",
year = "2018",
month = "4",
doi = "10.1002/pon.4655",
language = "English (US)",
volume = "27",
pages = "1221--1228",
journal = "Psycho-Oncology",
issn = "1057-9249",
publisher = "John Wiley and Sons Ltd",
number = "4",

}

Brown, JC, Damjanov, N, Courneya, KS, Troxel, AB, Zemel, BS, Rickels, MR, Ky, B, Rhim, AD, Rustgi, AK & Schmitz, KH 2018, 'A randomized dose-response trial of aerobic exercise and health-related quality of life in colon cancer survivors', Psycho-Oncology, vol. 27, no. 4, pp. 1221-1228. https://doi.org/10.1002/pon.4655

A randomized dose-response trial of aerobic exercise and health-related quality of life in colon cancer survivors. / Brown, Justin C.; Damjanov, Nevena; Courneya, Kerry S.; Troxel, Andrea B.; Zemel, Babette S.; Rickels, Michael R.; Ky, Bonnie; Rhim, Andrew D.; Rustgi, Anil K.; Schmitz, Kathryn H.

In: Psycho-Oncology, Vol. 27, No. 4, 04.2018, p. 1221-1228.

Research output: Contribution to journalArticle

TY - JOUR

T1 - A randomized dose-response trial of aerobic exercise and health-related quality of life in colon cancer survivors

AU - Brown, Justin C.

AU - Damjanov, Nevena

AU - Courneya, Kerry S.

AU - Troxel, Andrea B.

AU - Zemel, Babette S.

AU - Rickels, Michael R.

AU - Ky, Bonnie

AU - Rhim, Andrew D.

AU - Rustgi, Anil K.

AU - Schmitz, Kathryn H.

PY - 2018/4

Y1 - 2018/4

N2 - Objective: To examine the dose-response effects of aerobic exercise on health-related quality of life (HRQoL) among colon cancer survivors. Methods: Thirty-nine stage I to III colon cancer survivors were randomized to 1 of 3 groups: usual-care control, 150 min·wk −1 of aerobic exercise (low-dose) and 300 min·wk −1 of aerobic exercise (high-dose) for 6 months. HRQoL outcomes included the Short Form (SF)-36 physical and mental component summary, Functional Assessment of Cancer Therapy-Colorectal, Pittsburgh Sleep Quality Index, Fear of Cancer Recurrence Inventory, Fatigue Symptom Inventory, and North Central Cancer Treatment Group bowel function questionnaire, assessed at baseline and post intervention. The primary hypothesis was that exercise would improve HRQoL outcomes in a dose-response fashion, such that high-dose aerobic exercise would yield the largest improvements in HRQoL outcomes. Results: Over 6 months, the low-dose group completed 141 ± 10 min·wk −1 of aerobic exercise, and the high-dose group completed 247 ± 11 min·wk −1 of aerobic exercise. Over 6 months, exercise improved the physical component summary score of the SF-36 (P trend  = 0.002), the Functional Assessment of Cancer Therapy-Colorectal (P trend  = 0.025), the Pittsburgh Sleep Quality Index (P trend  = 0.049), and the Fatigue Symptom Inventory (P trend  = 0.045) in a dose-response fashion. Between-group standardized mean difference effects sizes for the above-described findings were small to moderate in magnitude (0.35–0.75). No dose-response effects were observed for the mental component summary score of the SF-36, the Fear of Cancer Recurrence Inventory, or bowel function. Conclusion: Higher doses of aerobic exercise, up to 300 min·wk −1 , improve multiple HRQoL outcomes among stage I to III colon cancer survivors. These findings provide evidence that aerobic exercise may provide multiple health benefits for colon cancer survivors.

AB - Objective: To examine the dose-response effects of aerobic exercise on health-related quality of life (HRQoL) among colon cancer survivors. Methods: Thirty-nine stage I to III colon cancer survivors were randomized to 1 of 3 groups: usual-care control, 150 min·wk −1 of aerobic exercise (low-dose) and 300 min·wk −1 of aerobic exercise (high-dose) for 6 months. HRQoL outcomes included the Short Form (SF)-36 physical and mental component summary, Functional Assessment of Cancer Therapy-Colorectal, Pittsburgh Sleep Quality Index, Fear of Cancer Recurrence Inventory, Fatigue Symptom Inventory, and North Central Cancer Treatment Group bowel function questionnaire, assessed at baseline and post intervention. The primary hypothesis was that exercise would improve HRQoL outcomes in a dose-response fashion, such that high-dose aerobic exercise would yield the largest improvements in HRQoL outcomes. Results: Over 6 months, the low-dose group completed 141 ± 10 min·wk −1 of aerobic exercise, and the high-dose group completed 247 ± 11 min·wk −1 of aerobic exercise. Over 6 months, exercise improved the physical component summary score of the SF-36 (P trend  = 0.002), the Functional Assessment of Cancer Therapy-Colorectal (P trend  = 0.025), the Pittsburgh Sleep Quality Index (P trend  = 0.049), and the Fatigue Symptom Inventory (P trend  = 0.045) in a dose-response fashion. Between-group standardized mean difference effects sizes for the above-described findings were small to moderate in magnitude (0.35–0.75). No dose-response effects were observed for the mental component summary score of the SF-36, the Fear of Cancer Recurrence Inventory, or bowel function. Conclusion: Higher doses of aerobic exercise, up to 300 min·wk −1 , improve multiple HRQoL outcomes among stage I to III colon cancer survivors. These findings provide evidence that aerobic exercise may provide multiple health benefits for colon cancer survivors.

UR - http://www.scopus.com/inward/record.url?scp=85042185277&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85042185277&partnerID=8YFLogxK

U2 - 10.1002/pon.4655

DO - 10.1002/pon.4655

M3 - Article

C2 - 29388275

AN - SCOPUS:85042185277

VL - 27

SP - 1221

EP - 1228

JO - Psycho-Oncology

JF - Psycho-Oncology

SN - 1057-9249

IS - 4

ER -